Screener
Stoke Therapeutics, Inc. STOK Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.93B.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
FAQ
- What is Stoke Therapeutics, Inc.'s market capitalization?
- Stoke Therapeutics, Inc. (STOK) reported market capitalization of $1.93B in Q1 2026.
- How has Stoke Therapeutics, Inc.'s market capitalization changed year-over-year?
- Stoke Therapeutics, Inc.'s market capitalization increased by 435.6% year-over-year, from $359.62M to $1.93B.
- What is the long-term trend for Stoke Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s market capitalization has grown at a -4.5% compound annual growth rate (CAGR), from $2.28B to $1.81B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Stoke Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude